The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2002

Filed:

Oct. 26, 1999
Applicant:
Inventors:

Pramod K. Srivastava, Riverdale, NY (US);

Rajiv Y. Chandawarkar, Mineola, NY (US);

Assignee:

Fordham University, Bronx, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 3/9385 ; A61K 3/938 ; A61K 3/816 ; A61K 3/817 ; C07K 7/00 ;
U.S. Cl.
CPC ...
A61K 3/9385 ; A61K 3/938 ; A61K 3/816 ; A61K 3/817 ; C07K 7/00 ;
Abstract

The present invention relates to methods and compositions for eliciting an immune response and the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases. The methods of the invention comprise administering a composition comprising an effective amount of a complex, in which the complex consists essentially of a heat shock protein (hsp) noncovalently bound to an antigenic molecule. Optionally, the methods further comprise administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule. “Antigenic molecule” as used herein refers to the peptides with which the hsps are endogenously associated in vivo as well as exogenous antigens/immunogens (i.e., with which the hsps are not complexed in vivo) or antigenic/immunogenic fragments and derivatives thereof. In a preferred embodiment, the complex is autologous to the individual. In a specific embodiment; the effective amounts of the complex are in the range of 0.1 to 9.0 micrograms for complexes comprising hsp70, 5 to 49 micrograms for hsp90, and 0.1 to 9.0 micrograms for gp96.


Find Patent Forward Citations

Loading…